Identification of a highly conserved surface on Tat variants

Area of Science:

• Immunology
• Virology
• Biochemistry

Background:

• Extracellular HIV-1 Tat protein aids viral immune evasion.
• Neutralizing antibodies against Tat are absent in infected patients, even under treatment.
• The Tat OYI vaccine candidate elicits neutralizing antibodies in mice.

Purpose of the Study:

• To design and characterize a peptide mimetic of the Tat OYI vaccine's epitope.
• To evaluate the immunogenicity and cross-reactivity of the peptide mimetic.

Main Methods:

• Chemical synthesis and structural analysis (circular dichroism) of the MIMOOX peptide.
• Enzyme-linked immunosorbent assay (ELISA) and competitive recognition assays using mAb 7G12.
• Immunization of rats with MIMOOX and subsequent antibody analysis.

Main Results:

• MIMOOX peptide adopted a stable structure with β turns.
• MIMOOX was recognized by mAb 7G12 under reduced conditions, indicating epitope mimicry.
• Antibodies induced by MIMOOX recognized diverse HIV-1 Tat variants, validating the Tat OYI vaccine strategy.

Conclusions:

• MIMOOX effectively mimics a conserved surface epitope of HIV-1 Tat.
• The MIMOOX peptide represents a promising candidate for developing a broadly protective HIV-1 vaccine.